|
AP16788b-ev
|
Abcepta, Inc.
|
EIF3K [C-term] [RB35950], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP16788b
|
Abcepta, Inc.
|
EIF3K [C-term] [RB35950], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
ATGP3351-250ug
|
NKMax Bio (ATGen)
|
Integrin alpha L beta 2 [23-700 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3351-50ug
|
NKMax Bio (ATGen)
|
Integrin alpha L beta 2 [23-700 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
GTX64552
|
GeneTex International Corporation
|
EIF3K, Rabbit Polyclonal Antibody
|
Human, Rat
|
WB
|
|
|
HY-10505-10mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10505-25mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10505-5mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10505-50mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
|
HY-112815-10mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112815-100mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112815-25mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112815-5mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112815-50mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-122652-100mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-122652-25mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-122652-50mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-134188-1mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-10mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-100mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-25mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-5mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-50mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-19987-10mg
|
MedChemexpress LLC
|
BML-284 [CAS 853220-52-7]
|
|
Cancer-programmed cell death
|
|
|
HY-19987-100mg
|
MedChemexpress LLC
|
BML-284 [CAS 853220-52-7]
|
|
Cancer-programmed cell death
|
|
